WO1999022011A1 - Reduction of chlorophyll content in oil plant seeds - Google Patents
Reduction of chlorophyll content in oil plant seeds Download PDFInfo
- Publication number
- WO1999022011A1 WO1999022011A1 PCT/EP1998/006852 EP9806852W WO9922011A1 WO 1999022011 A1 WO1999022011 A1 WO 1999022011A1 EP 9806852 W EP9806852 W EP 9806852W WO 9922011 A1 WO9922011 A1 WO 9922011A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- promoter
- plants
- seeds
- plant
- chlorophyll
- Prior art date
Links
- 229930002875 chlorophyll Natural products 0.000 title claims abstract description 67
- 235000019804 chlorophyll Nutrition 0.000 title claims abstract description 67
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 title claims abstract description 65
- 230000009467 reduction Effects 0.000 title abstract description 9
- 241000196324 Embryophyta Species 0.000 claims abstract description 118
- 238000000034 method Methods 0.000 claims abstract description 37
- 240000002791 Brassica napus Species 0.000 claims abstract description 35
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 33
- 230000000692 anti-sense effect Effects 0.000 claims abstract description 31
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 27
- 239000003921 oil Substances 0.000 claims abstract description 17
- 235000019198 oils Nutrition 0.000 claims abstract description 17
- 235000011293 Brassica napus Nutrition 0.000 claims abstract description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 9
- 239000008158 vegetable oil Substances 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 49
- 230000009261 transgenic effect Effects 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 14
- 150000007523 nucleic acids Chemical group 0.000 claims description 14
- 108010057891 Glutamate-1-semialdehyde 2,1-aminomutase Proteins 0.000 claims description 13
- 238000012546 transfer Methods 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims description 7
- 108091026890 Coding region Proteins 0.000 claims description 7
- 108010086470 magnesium chelatase Proteins 0.000 claims description 5
- 238000013518 transcription Methods 0.000 claims description 5
- 230000035897 transcription Effects 0.000 claims description 5
- 108010015514 Glutamate-tRNA ligase Proteins 0.000 claims description 4
- 108010023021 Glutamyl-tRNA reductase Proteins 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000011069 regeneration method Methods 0.000 claims description 4
- 101710168820 2S seed storage albumin protein Proteins 0.000 claims description 3
- 108010068370 Glutens Proteins 0.000 claims description 3
- 101710094902 Legumin Proteins 0.000 claims description 3
- 101710202365 Napin Proteins 0.000 claims description 3
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical group [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims description 3
- 210000002706 plastid Anatomy 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- 102000001861 Glutamyl-tRNA synthetases Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 48
- 241000894007 species Species 0.000 abstract 1
- 239000013598 vector Substances 0.000 description 24
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 18
- 229960002749 aminolevulinic acid Drugs 0.000 description 18
- 239000002609 medium Substances 0.000 description 16
- 239000013612 plasmid Substances 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 11
- 239000006870 ms-medium Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 229920000936 Agarose Polymers 0.000 description 7
- 235000019484 Rapeseed oil Nutrition 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000001938 protoplast Anatomy 0.000 description 7
- MPUUQNGXJSEWTF-BYPYZUCNSA-N (S)-4-amino-5-oxopentanoic acid Chemical compound O=C[C@@H]([NH3+])CCC([O-])=O MPUUQNGXJSEWTF-BYPYZUCNSA-N 0.000 description 6
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 6
- 229960003669 carbenicillin Drugs 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- 108020005544 Antisense RNA Proteins 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000010353 genetic engineering Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 235000006008 Brassica napus var napus Nutrition 0.000 description 4
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 4
- 102000003929 Transaminases Human genes 0.000 description 4
- 108090000340 Transaminases Proteins 0.000 description 4
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 4
- 239000003184 complementary RNA Substances 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 229930195712 glutamate Natural products 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 102000001888 Glutamate-tRNA ligase Human genes 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 241000208125 Nicotiana Species 0.000 description 3
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229940040102 levulinic acid Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical class CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 240000008100 Brassica rapa Species 0.000 description 2
- WDFJYRZCZIUBPR-UHFFFAOYSA-N Hydroxymethylbilane Natural products OC(=O)CC1=C(CO)NC(CC2=C(C(CCC(O)=O)=C(CC3=C(C(CCC(O)=O)=C(CC4=C(C(CCC(O)=O)=CN4)CC(O)=O)N3)CC(O)=O)N2)CC(O)=O)=C1CCC(O)=O WDFJYRZCZIUBPR-UHFFFAOYSA-N 0.000 description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- VONNLLSMCGYFIZ-UHFFFAOYSA-N hydroxymethylbilane Chemical compound OC(=O)C[C]1C(CO)=NC(CC=2[C](C(CCC(O)=O)=C(CC=3[C](C(CCC(O)=O)=C(CC=4[C](C(CCC(O)=O)=CN=4)CC(O)=O)N=3)CC(O)=O)N=2)CC(O)=O)=C1CCC(O)=O VONNLLSMCGYFIZ-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
- 229960001669 kinetin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- NMKJJVNCRCSYDT-UHFFFAOYSA-N 1-benzylpurin-2-amine Chemical compound NC1=NC2=NC=NC2=CN1CC1=CC=CC=C1 NMKJJVNCRCSYDT-UHFFFAOYSA-N 0.000 description 1
- 239000005971 1-naphthylacetic acid Substances 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000011292 Brassica rapa Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- QSHWIQZFGQKFMA-UHFFFAOYSA-N Porphobilinogen Natural products NCC=1NC=C(CCC(O)=O)C=1CC(O)=O QSHWIQZFGQKFMA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 108091000085 chlorophyll binding Proteins 0.000 description 1
- 108010081694 chlorophyll synthetase Proteins 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- NIUVHXTXUXOFEB-UHFFFAOYSA-N coproporphyrinogen III Chemical compound C1C(=C(C=2C)CCC(O)=O)NC=2CC(=C(C=2C)CCC(O)=O)NC=2CC(N2)=C(CCC(O)=O)C(C)=C2CC2=C(C)C(CCC(O)=O)=C1N2 NIUVHXTXUXOFEB-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000010720 hydraulic oil Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical group CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- YPHQRHBJEUDWJW-UHFFFAOYSA-N porphobilinogen Chemical compound NCC1=NC=C(CCC(O)=O)[C]1CC(O)=O YPHQRHBJEUDWJW-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000037343 tetrapyrrole metabolism Effects 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HUHWZXWWOFSFKF-UHFFFAOYSA-N uroporphyrinogen-III Chemical compound C1C(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(N2)=C(CC(O)=O)C(CCC(=O)O)=C2CC2=C(CCC(O)=O)C(CC(O)=O)=C1N2 HUHWZXWWOFSFKF-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
Definitions
- the present invention relates to methods for reducing the chlorophyll content in seeds of oil plants, in particular rapeseed, based on the expression of antisense genes in chlorophyll synthesis.
- the invention further relates to seeds of oil plants which have a reduced chlorophyll content compared to wild type plants, and to the use of these seeds for the production of vegetable oils.
- the cruciferous oilseed rape (Brassica napus) and turnip rape (Brassica rapa) are among the most important oil plants alongside soybeans and cottonseed.
- the seeds of rapeseed contain around 40% fatty oil, the so-called rapeseed or turnip oil, which is usually obtained from the crushed seeds by pressing or extraction in a yield of approx. 40% and then subjected to refining.
- the rapeseed oil obtained can then be used as cooking oil, mineral lubricant oil additive, after fat hardening for margarine production and as a raw material in the production of tree wax, plasters, leather greasing agents, etc.
- Rapeseed oil is also known as a good source of C 20 and C 22 fatty acids, which are important as plastic processing and washing aids.
- vegetable oils, and in particular rapeseed oil are also becoming increasingly important as biodiesel fuels.
- biodiesel fuels In general, the areas of application of vegetable oils have been significantly expanded in recent years. With increasing environmental awareness, increasingly more environmentally friendly industrial products, such as lubricants and hydraulic oils, were developed.
- the pigments contained in the seeds, especially the chlorophylls, and their photosensitive precursors have to be extracted in a complex manner. Apart from the fact that these extractions are time and cost intensive, they always mean a loss of the rapeseed oil yield. Although turnips have somewhat lower requirements than rapeseed in terms of vegetation duration and location, similar problems arise for these Brassicaceae in terms of seed ripening and excess chlorophyll content. The extraction and use of rapeseed oil largely corresponds to that for rapeseed oil.
- ALA 5-aminolevulinic acid
- glutamate via three enzyme activities (glutamyl tRNA synthetase, glutamyl tRNA reductase and glutamate 1-semialdehyde aminotransferase).
- the protopophyrin IX is formed from hydroxymethylbilane by oxidation and side chain modifications via uroporphyrinogen III, coproporphyrinogen and protopophyrinogen IX.
- the incorporation of a divalent metal cation produces magnesium protopophyrin IX, which is converted into chlorophyll a by further modifications, which include the incorporation of an additional isocyclic ring on ring B and the particularly important esterification of a propionate with a phytol chain.
- European patent application 0 779 364 A2 describes an approach to reducing the chlorophyll content in transgenic plants, in which the transcript and protein content of the chlorophyll-binding proteins (chlorophyll a / b binding (CAB) proteins) of the antenna complex of Photosystem II (light harvesting complex associated with photosystem II, LHCII) is reduced.
- This approach which is based on the expression of antisense genes for LHCII, therefore relates to proteins which bind already synthesized chlorophyll in Photosystem II, but not to enzymes which are directly involved in chlorophyll synthesis.
- transgenic plant seeds with a reduced chlorophyll content compared to seeds of wild-type plants.
- the present invention thus relates to the use of DNA sequences which code for enzymes in chlorophyll synthesis and whose targeted transfer to and expression in transgenic plant cells results in a reduction in chlorophyll synthesis. More specifically, the invention relates to the transfer of suitable antisense gene constructs to plants and their expression in the seed tissue.
- the invention is based on experiments in which the amount of chlorophyll in plant seeds could be significantly reduced by the seed-specific expression of antisense genes against certain enzyme steps in tetrapyrrole synthesis and the resultant seed-specific inhibition of the activity of defined enzymes in chlorophyll synthesis.
- Antisense genes which code complementary to the endogenous RNA for enzymes of the tetrapyrrole metabolism, reduce the endogenous RNA contents or the number of RNA molecules available for the subsequent protein biosynthesis.
- a reduced content of endogenous RNA inevitably leads to a reduced translation, that is to say a reduced amount of protein, which in turn manifests itself in a reduced activity of the target enzyme.
- the invention relates to all genes whose gene products catalyze steps of tetrapyrrole synthesis. Since the expression and activity of any enzyme involved in tetrapyrrole synthesis can be reduced or inhibited by targeted antisense RNA synthesis, the method according to the invention for reducing the chlorophyll content in sperm cells can use all genes of this metabolic pathway, ie also individually or in combination , be performed.
- genes are primarily genes which are responsible for glutamyl tRNA synthetase, glutamyl tRNA reductase, glutamate 1 semialdehyde aminotransferase, magnesium chelatase or their subunits CHL I, Code CHL D, CHL H, chlorophyll synthetase and Mg protopophyrin monomethyl ester transferase.
- the invention also relates to fragments of such genes involved in chlorophyll synthesis, the use of which within an antisense construct results in reduced activity of the target enzyme.
- Such fragments could be referred to in the context of this invention as "antisense active" fragments, i.e. their transfer in the form of a suitable construct reduces the corresponding endogenous enzyme activity.
- the invention relates to the use of alleles and derivatives of the genes according to the invention for reducing the chlorophyll content in plant seeds, thus also the use of nucleic acid molecules whose sequences differ from the genes according to the invention due to the degeneration of the genetic code and their transmission to plant cells in one go the
- nucleic acid molecules which contain the antisense genes according to the invention or which have arisen from, or have been derived from, naturally occurring or by genetic engineering or chemical processes and synthesis processes.
- This can be, for example, DNA or RNA molecules, cDNA, genomic DNA, mRNA etc.
- GSA-AT glutamate 1 semialdehyde aminotransferase
- GSA glutamate 1-semialdehyde
- ALA aminolevulinic acid
- GSA-AT The expression of a tobacco antisense RNA for GSA-AT has so far only been investigated in leaves of tobacco plants (Höfgen et al. (1994) Proc. Natl. Acad. Sei. USA 91, 1726-1730).
- DNA sequences from two tobacco full-length cDNA clones are in the GenBank, Accession Nos. X65973 and X65974 are available.
- a gene of chlorophyll synthesis or a fragment thereof preferably the coding region of such a gene or fragment, is in the antisense orientation, ie 3 '->5' orientation, with the 3 'end a promoter, i.e. a regulatory element that ensures the transcription of the linked gene in plant cells.
- genes according to the invention can be expressed in plant cells under the control of constitutive, but also inducible or tissue or development-specific promoters. These are preferably seed-specific promoters, the use of which enables the targeted inhibition of chlorophyll synthesis in sperm cells.
- seed-specific promoters that can be used in connection with the invention, mention should be made of the USP promoter (described, inter alia, in: Bäumlein et al. (1991) Mol. Gen. Genet. 459-467; Fiedler et al. ( 1993) Plant Mol. Biol. 22, 669-679; DE-C2-39 20 034), the napin promoter (Ericson et al. (1991) Eur. J. Biochem. 197, 741-746; Accession No. X 58142), the 2S albumin promoter (Krebbers et al. (1988) Plant Physiol. 87, 859-866; Accession No.
- legumin promoter (Bäumlein et al. (1986) Nucl. Acids Res. 14, 2707-2720; Accession No. X 03677) and the Hordein promoter (Entwistle et al. (1991) Plant Mol. Biol. 17, 1217-1231; Accession No. X 60037).
- the antisense constructs used according to the invention can additionally comprise enhancer sequences or other regulatory sequences. It is also an object of the invention to provide new plants, plant cells, parts or products which are distinguished by a reduced chlorophyll content compared to wild type plants.
- the antisense nucleic acid molecules according to the invention are transferred to plants.
- the transgenic oilseed rape plants are particularly preferably summer oilseed rape plants.
- OO rapeseed plants are also suitable for the use of the processes according to the invention, i.e. Rapeseed plants that are free of erucic acid and low in glucosinolate.
- the plants that are transformed with the nucleic acid molecules according to the invention and in which a smaller amount of chlorophylls are synthesized due to the integration of such a molecule into their genome can in principle be any plant. It is preferably an oil plant, such as oilseed rape and turnips, from which vegetable oil is obtained, in the production of which high chlorophyll contents are undesirable.
- the invention relates in particular to propagation material from plants according to the invention, for example seeds, fruits.
- Cuttings, tubers, rhizomes etc., this material may be above contains described transgenic plant cells, and parts of these plants such as protoplasts, plant cells and calli; seeds are particularly preferred.
- the present invention is also based on the object of providing processes for producing plant cells and plants and parts thereof, in particular seeds, which are distinguished by a reduced chlorophyll content.
- plant cells which have a reduced chlorophyll content due to the expression of an antisense gene construct according to the invention are produced by a process which comprises the following steps:
- an expression cassette which comprises the following DNA sequences: a promoter which ensures transcription in plant cells; at least one nucleic acid sequence encoding an enzyme or a fragment thereof that is involved in chlorophyll synthesis, the nucleic acid sequence being coupled in antisense orientation to the 3 'end of the promoter; and optionally a termination signal for the termination of the transcription and the addition of a poly-A tail to the corresponding transcript which is coupled to the 5 'end of the nucleic acid sequence.
- the invention relates to the use of the antisense constructions according to the invention for producing plants, in particular plant seeds, which have a reduced chlorophyll content.
- the invention preferably relates to the use of the antisense constructions according to the invention for the production of seeds from oil plants, particularly preferably from rapeseed and turnips, which have a reduced chlorophyll content.
- Another object of the invention is to record the possibilities of using the plants according to the invention or their cells, parts and products, in particular their seeds.
- the invention relates in particular to the use of the plants according to the invention, in particular their seeds, for obtaining vegetable oils as raw materials for the chemical, cosmetic, pharmaceutical and food industries and as an energy source.
- the plants according to the invention thus represent an important source for the production of vegetable oils, in particular rapeseed and turnip oils for a broad spectrum of commercial purposes.
- Transformation selected plant functional promoter into consideration which fulfills the condition that the expression regulated by it leads to a reduced chlorophyll synthesis performance in plant cells.
- promoters which ensure seed-specific expression appear particularly useful for this purpose. Examples of such promoters are the above-mentioned USP, napin, 2S-albumin, legumin and hordein promoters.
- RNA + RNA is isolated from seed tissue and a cDNA library is created.
- cDNA clones based on poly (A) * RNA molecules from a non-seed tissue are used to identify those clones from the first bank whose hybrid poly (A) + RNA Molecules are only expressed in the seed tissue. Promoters are then isolated with the help of these cDNAs identified in this way, which can then be used for the expression of the antisense.
- cloning vectors which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells.
- examples of such vectors are pBR322, pUC series, M13mp series, pACYC184 etc.
- the desired sequence can be matched to a suitable one - 1:
- Restriction interface to be introduced into the vector The plasmid obtained is used for the transformation of E. co // cells. Transformed E. coli cells are grown in a suitable medium and then harvested and lysed. The plasmid is recovered. Restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are generally used as the analysis method for characterizing the plasmid DNA obtained. After each manipulation, the plasmid DNA can be cleaved and DNA fragments obtained can be linked to other DNA sequences. Each plasmid DNA sequence can be cloned into the same or different plasmids.
- a large number of known techniques are available for introducing DNA into a plant host cell, and the person skilled in the art can determine the appropriate method in each case without difficulty. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as a transformation agent, the fusion of protoplasts, the direct gene transfer of isolated DNA to protoplasts, the electroporation of DNA, the introduction of DNA using the biolistic method as well as other options.
- plasmids When injecting and electroporation of DNA into plant cells, there are no special requirements per se for the plasmids used. The same applies to direct gene transfer. Simple plasmids such as pUC derivatives can be used. However, if whole plants are to be regenerated from such transformed cells, the presence of a selectable marker gene is necessary. The usual selection markers are known to the person skilled in the art and it is no problem for him to select a suitable marker. Depending on the method of introducing desired genes into the plant cell, additional DNA sequences may be required.
- the Ti or Ri plasmid is used for the transformation of the plant cell, at least the right boundary, but often the right and left boundary of the T-DNA contained in the Ti and Ri plasmid, must be connected as a flank region to the genes to be introduced .
- the DNA to be introduced must be cloned into special plasmids, either in an intermediate or in a binary vector.
- the intermediate vectors can be integrated into the Ti or Ri plasmid of the agrobacteria on the basis of sequences which are homologous to sequences in the T-DNA by homologous recombination. This also contains the vir region necessary for the transfer of the T-DNA.
- Intermediate vectors cannot replicate in agrobacteria.
- the intermediate vector can be transferred to Agrobacterium tumefaciens using a helper phasmid (conjugation).
- Binary vectors can replicate in E. coli as well as in Agrobacteria.
- T-DNA border region They contain a selection marker gene and a linker or polylinker, which are framed by the right and left T-DNA border region. They can be transformed directly into the agrobacteria (Holsters et al. (1978) Molecular and General Genetics 163, 181-187). Serving as host cell should contain a plasmid of Agrobacterium carrying a vz 'R region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present. The agrobacterium transformed in this way is used to transform plant cells.
- T-DNA for the transformation of plant cells has been intensively investigated and is sufficient in EP 120 515; Hoekema in: The Binary Plant Vector System, Offsetdrokkerij Kanters BV, Alblasserdam (1985) Chapter V; Fraley et al. (1993) Crit. Rev. Plant. Sci., 4, 1-46 and An et al. (1985) EMBO J. 4, 277-287.
- plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes.
- Whole plants can then be regenerated from the infected plant material (e.g. leaf pieces, stem segments, roots, but also protoplasts or suspension-cultivated plant cells) in a suitable medium, which may contain antibiotics or biocides for the selection of transformed cells.
- the plants are regenerated using conventional regeneration methods using known nutrient media.
- the plants thus obtained can then be examined for the presence of the introduced DNA.
- Other ways of introducing foreign DNA using the biolistic method or by protoplast transformation are known (cf., for example, Willmitzer L.
- the introduced DNA is integrated in the genome of the plant cell, it is generally stable there and is also retained in the progeny of the originally transformed cell. It normally contains a selection marker which gives the transformed plant cells resistance to a biocide or an antibiotic such as kanamycin, G418, bleomycin, hygromycin, methotrexate, glyphosate, streptomycin, sulfonylurea, gentamycin or phosphinotricin and others.
- the individually selected marker should therefore allow the selection of transformed cells from cells that lack the inserted DNA.
- the transformed cells grow within the plant in the usual way (see also McCormick et al. (1986) Plant Cell Reports 5, 81-84).
- the resulting plants can be grown normally and crossed with plants that have the same transformed genetic makeup or other genetic makeup.
- the resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plants.
- Two or more generations should be grown to ensure that the phenotypic trait is stably maintained and inherited. Seeds should also be harvested to ensure that the appropriate phenotype or other characteristics have been preserved.
- transgenic lines can be determined using conventional methods, which are homozygous for the new nucleic acid molecules and which investigate their phenotypic behavior with regard to a changed chlorophyll content and compare them with that of hemizygotic lines.
- the transmission and expression of the antisense gene constructs according to the invention can be carried out with the aid of conventional molecular biological and biochemical methods. These techniques are known to the person skilled in the art and he is easily able to choose a suitable detection method, for example a Northern blot analysis for the qualitative and quantitative detection of RNA which is specific for the coding region of the respective antisense gene, or a Southern -Blot analysis to identify the transferred DNA sequences.
- a suitable detection method for example a Northern blot analysis for the qualitative and quantitative detection of RNA which is specific for the coding region of the respective antisense gene, or a Southern -Blot analysis to identify the transferred DNA sequences.
- transgenic plant cells or plants as well as parts and products thereof can then be examined for their chlorophyll content.
- analysis methods are available:
- a reduced chlorophyll content of the transgenic plants or their parts and products compared to wild-type plants can often also be seen with the naked eye or with the aid of optical aids.
- Example 1 Preparation of an antisense construct based on DNA sequences which code for a glutamate 1 semialdehyde aminotransferase from tobacco
- the vector pP30T which contains the USP promoter from Viceafaba, was a pUC18 derivative (see also Bäumlein et al. (1991) supra), cut with PstI and Bglll.
- the isolated USP promoter fragment was then cloned into a BamHI / Pstl-cut pBluescript vector (-> pUSPblue). This vector construct pUSPblue was then cut with EcoRI and Xbal to obtain an EcoRI / Xbal promoter fragment.
- the 35S CaMV promoter was removed from the binary vector BinAR by restriction digestion with EcoRI and Xbal and replaced by this seed-specific promoter by ligation of the EcoRI / Xbal vector fragment with the USP promoter fragment (-> pUSPbin).
- the complete cDNA sequence (Xbal - 3 '- GSA-AT-cDNA - 5' -Sall) of the tobacco-GSA aminotransferase cut from the pBluescript with Xbal and Sall was used in the Xbal-Sall-cut pUSPbin.
- the resulting binary vector was named pUSPASGSAT (see also Figure 2).
- any vector suitable for plant transformation can be used to produce an antisense gene consisting of a fusion of a promoter, preferably a seed-specific promoter, which ensures transcription and translation in plant cells, and DNA sequences which code for enzymes involved in chlorophyll synthesis are used.
- a promoter preferably a seed-specific promoter, which ensures transcription and translation in plant cells, and DNA sequences which code for enzymes involved in chlorophyll synthesis are used.
- a recombinant culture of Agrobacterium tumefaciens was washed and in medium 1 (MS medium (Murashige and Skoog (1962) Physiol. Plant 15, 473), 2.5 mM MES pH 5.5, 1 mg / 1 benzylaminopurine (BAP), 0.1 mg / 1 naphthylacetic acid (NAA), 0.01 mg / 1 gibberelic acid (GA 3 ), 200 ⁇ M acetosyringone).
- hypocotyl of 14-day-old Brassica " ⁇ pw ⁇ seedlings was cut into 0.5 to 1 cm long segments, with the bacterial suspension for 30 min. incubated and then stored for 5 days in the dark at 21 ° C. on medium 1 containing 0.7% agar.
- hypocotyl was at 25 ° C on medium 2 (MS medium, 2.5 mM MES pH 5.7, 30 g / 1 sucrose, 1 mg / 1 kinetin, 1 mg / 1 2,4-dichloropheneoxyacetic acid (2nd , 4-D), 0.01 mg / 1 GA 3 , 500 mg / 1 polyvinylpyrrolidone (PVP), 5 mg / 1 AgNO 3 , 5 g / 1 agarose, 250 mg / 1 carbenicillin, 100 mg / 1 kanamycin; at 150 ⁇ M photon / ⁇ r / sec).
- MS medium MS medium, 2.5 mM MES pH 5.7, 30 g / 1 sucrose, 1 mg / 1 kinetin, 1 mg / 1 2,4-dichloropheneoxyacetic acid (2nd , 4-D), 0.01 mg / 1 GA 3 , 500 mg / 1 polyvinylpyrrolidone (PVP), 5 mg / 1 AgNO 3 , 5
- shoot induction was carried out on medium 3 (MS medium, 2.5 mM MES pH 5.5, 20 g / 1 sucrose, 40 mg / 1 adenine, 1 mg / 1 BAP, 0.1 mg / 1 NAA , 0.01 mg / 1 GA 3 , 500 mg / 1 PVP, 5 mg / 1 AgNO 3 , 100 mg / 1 kanamycin, 5 g / 1 agarose, 250 mg / 1 carbenicillin).
- MS medium 2.5 mM MES pH 5.5, 20 g / 1 sucrose, 40 mg / 1 adenine, 1 mg / 1 BAP, 0.1 mg / 1 NAA , 0.01 mg / 1 GA 3 , 500 mg / 1 PVP, 5 mg / 1 AgNO 3 , 100 mg / 1 kanamycin, 5 g / 1 agarose, 250 mg / 1 carbenicillin).
- the calli which showed shoots, were placed on shoot extension medium (medium 4) in glass vessels (MS medium, 2.5 mM MES pH 5.7, 10 g / 1 sucrose, 0.0025 mg / 1 BAP, 100 mg / 1 kanamycin, 7 g / 1 agarose, 250 mg / 1 carbenicillin). After about 2-3 weeks, the shoots were transferred to medium 5 (MS medium, 2.5 mM MES pH 5.5, 7 g / 1 agarose) to form roots.
- medium 4 MS medium, 2.5 mM MES pH 5.7, 10 g / 1 sucrose, 0.0025 mg / 1 BAP, 100 mg / 1 kanamycin, 7 g / 1 agarose, 250 mg / 1 carbenicillin.
- transgenic oilseed rape plants were produced according to the following protocol: A recombinant culture of Agrobacterium tumefaciens (strain GV 3101) was washed and resuspended in MS medium with 2.5 mM MES pH 5.5. The hypocotyl of rape seedlings 5-7 days old was cut into explants approximately 7 mm long and precultivated in liquid CIM medium for 24 hours. The explants were then co-cultivated in 10 ml of the CIM medium with 50 ⁇ l of an overnight culture of the recombinant Agrobacterium strain for 2-3 days in the dark.
- the CIM medium consists (per liter) of MS medium, 30 g sucrose, 500 mg MES pH 5.8, 1 mg 2.4 D, 1 mg kinetin.
- the hypocotyl pieces were then washed and cultured on CIM medium with 5 g / 1 agarose, 20 mg kanamycin, 250 mg betabactyl, 250 mg carbenicillin for 7-10 days for callus induction.
- the slightly swollen explants were then placed on SIM medium for shoot induction. The medium was renewed every 10-14 days.
- the SIM medium consists (per liter) of MS medium, vitamins, 20 g sucrose, 500 mg MES pH 5.6-5.8, 2 mg zeatin, 2 mg BAP, 100 mg myo-inositol, 5 g agarose, 20 mg kanamycin, 500 mg betabactyl or carbenicillin. After the shoots had formed, the calli, which showed shoots, were placed in glass vessels with MS medium, 500 mg / 1 MES pH 5.7, 20 g / 1 sucrose, 20 mg / 1 kanamycin, 5 g / 1 agarose, 500 mg / 1 Carbenicillin transferred.
- rapeseed plants can also be transformed using other techniques.
- Moloney et al. (1989, Plant Cell Rep. 8. 238-242), in which an agrobacterial-mediated DNA transfer to cotyledons from 7 day old seedlings via the cut at the petiole.
- the transformation of protoplasts using cells of different tissues is suitable (e.g. described in Thomzik (1993) In: Biotechnology in agriculture and forestry, Vol. 23, Plant protoplasts and genetic engineering IV (Bajaj, ed.) Springer-Verlag, Berlin, 170-182).
- Plants that were transformed with the vector construct pUSPASGSAT were then examined for the expression of antisense RNA against GSA-AT.
- chlorophyll contents and synthesis rates in the transgenic plants were determined.
- chlorophylls were extracted from 100 mg of seed material ground in liquid nitrogen with buffered, ice-cold 80% acetone until the pellet had become colorless. The samples were diluted accordingly and the absorbance at 663, 646 and 750 nm was measured on the spectrophotometer. The formulas by Porra et al. (1989, supra).
- Chlorophyll extraction carried out and separated by HPLC.
- the extraction and separation was carried out according to the method of Gilmore and Yamamoto (1991, J. Chromatography 543, 137-145), modified by Kruse et al. (1995, EMBO J. 14, 3712-3720) as follows: 100 mg of seed material ground in liquid nitrogen were weighed and extracted with 100% acetone and 10 ⁇ M KOH until the pellet had become colorless (1 ⁇ 400 ⁇ l, 3 ⁇ 200 ⁇ l). The extracts were diluted 4: 1 with H 2 O for the HPLC runs in order to achieve sharper separations.
- the chlorophylls were measured using a LiChrospher 100 HPLC RP 18 column (5 ⁇ m, Merck) at a flow of 1 ml / min. eluted with the following gradient: 100% mobile solvent A (780 ml acetonitrile; 80 ml MeOH; 30 ml Tris / HCl 0.1 M pH
- Retention times that are known for the HPLC system can be assigned.
- the 5-aminolevulinic acid synthesis capacity in the transgenic plants was determined. Since enzyme activities in the C5 pathway cannot be determined without purifying the enzymes, indirect methods were chosen to measure the ability of ALA formation from glutamate. On the one hand, the accumulation of ALA after incubation of LA was determined according to the following protocol: 100-300 mg of seed tissue were mixed with 40 mM levulinic acid, a potent inhibitor (substrate analog) of ALA dehydratase (ALAD), in 20 mM K 2 per batch HPO 4 / KH 2 PO 4 (pH 7.1) incubated in the light for 2-4 h.
- ALAD potent inhibitor
- the plant material was frozen in liquid nitrogen, homogenized and mixed well after adding 1 ml of 20 mM K 2 HPO 4 / KH 2 PO 4 (pH 7.1).
- the ALA determination was carried out according to Mauzerall and Granick (1956, J. Biol. Chem. 219, 435-446). After centrifugation for 20 minutes at 15,000 g at 4 ° C., the same volume of 20 mM K 2 HPO 4 / KH 2 PO 4 (pH 7.1) and 100 ⁇ l of ethyl acetoacetate were pipetted into 250 ⁇ l of the supernatant. Samples that had been extracted without levulinic acid incubation at time t 0 served as a control. All samples were for exactly 10 min.
- Fig. 1 shows the metabolic pathway of tetrapyrrole biosynthesis
- Fig. 2 shows a restriction map of the binary described in Example 1
- Vector pUSP-ASGSAT which contains a fusion of the USP promoter and the region coding for GSA aminotransferase in antisense orientation.
- the vector pUSP-ASGSAT carries a kanamycin resistance gene as a plant selection marker.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98954461A EP1025248A1 (en) | 1997-10-29 | 1998-10-29 | Reduction of chlorophyll content in oil plant seeds |
AU11563/99A AU1156399A (en) | 1997-10-29 | 1998-10-29 | Reduction of chlorophyll content in oil plant seeds |
CA002306205A CA2306205A1 (en) | 1997-10-29 | 1998-10-29 | Reduction of chlorophyll content in oil plant seeds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19747739 | 1997-10-29 | ||
DE19747739.9 | 1997-10-29 | ||
DE19752647A DE19752647C1 (en) | 1997-10-29 | 1997-11-27 | Reduction of the chlorophyll content in oil plant seeds |
DE19752647.0 | 1997-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999022011A1 true WO1999022011A1 (en) | 1999-05-06 |
Family
ID=26041176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/006852 WO1999022011A1 (en) | 1997-10-29 | 1998-10-29 | Reduction of chlorophyll content in oil plant seeds |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1025248A1 (en) |
AU (1) | AU1156399A (en) |
CA (1) | CA2306205A1 (en) |
WO (1) | WO1999022011A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000075340A3 (en) * | 1999-06-04 | 2001-07-05 | Du Pont | Magnesium chelatase |
WO2001009355A3 (en) * | 1999-08-03 | 2001-09-07 | Basf Ag | PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF |
EP2522722A3 (en) * | 2005-12-09 | 2012-12-12 | BASF Plant Science GmbH | Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII |
CN118406702A (en) * | 2024-05-16 | 2024-07-30 | 华中农业大学 | Preparation method and application of brassica napus BnaCHL gene and mutant thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111066437B (en) * | 2019-12-11 | 2021-11-05 | 中国烟草总公司郑州烟草研究院 | Soil conditioning fluid for reducing chloride ion content in tobacco leaves and application method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0779364A2 (en) * | 1995-12-12 | 1997-06-18 | Her Majesty in Right of Canada, represented by The Minister of Agriculture and Agri-Food Canada | Anti-sense rna for cab transcript to reduce chlorophyll content in plants |
-
1998
- 1998-10-29 EP EP98954461A patent/EP1025248A1/en not_active Withdrawn
- 1998-10-29 WO PCT/EP1998/006852 patent/WO1999022011A1/en not_active Application Discontinuation
- 1998-10-29 CA CA002306205A patent/CA2306205A1/en not_active Abandoned
- 1998-10-29 AU AU11563/99A patent/AU1156399A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0779364A2 (en) * | 1995-12-12 | 1997-06-18 | Her Majesty in Right of Canada, represented by The Minister of Agriculture and Agri-Food Canada | Anti-sense rna for cab transcript to reduce chlorophyll content in plants |
Non-Patent Citations (5)
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000075340A3 (en) * | 1999-06-04 | 2001-07-05 | Du Pont | Magnesium chelatase |
US6570063B1 (en) | 1999-06-04 | 2003-05-27 | E.I. Dupont De Nemours And Company | Magnesium chelatase |
WO2001009355A3 (en) * | 1999-08-03 | 2001-09-07 | Basf Ag | PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF |
EP2522722A3 (en) * | 2005-12-09 | 2012-12-12 | BASF Plant Science GmbH | Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII |
CN118406702A (en) * | 2024-05-16 | 2024-07-30 | 华中农业大学 | Preparation method and application of brassica napus BnaCHL gene and mutant thereof |
Also Published As
Publication number | Publication date |
---|---|
EP1025248A1 (en) | 2000-08-09 |
AU1156399A (en) | 1999-05-17 |
CA2306205A1 (en) | 1999-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0765393B1 (en) | Dna molecules which code for a plastid 2-oxoglutarate/malate translocator | |
EP0973921B1 (en) | 2-deoxyglucose-6-phosphate (2-dog-6-p) phosphatase dna sequences as selection markers in plants | |
WO2001051647A2 (en) | Method for increasing the content of fatty acids in plants and micro-organisms | |
WO1999004021A1 (en) | Dna sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants | |
DE69528045T2 (en) | DNA CONSTRUCTIONS, CELLS AND THE PLANTS DERIVED FROM THEM | |
EP1102852A1 (en) | Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants | |
DE19752647C1 (en) | Reduction of the chlorophyll content in oil plant seeds | |
EP1301610B1 (en) | Method for influencing the content of sinapine in transgenic plant cells and plants | |
WO1995006733A2 (en) | Glycerin-3-phosphate-dehydrogenase (gpdh) | |
WO1999022011A1 (en) | Reduction of chlorophyll content in oil plant seeds | |
WO1998006831A1 (en) | Transgenic plant cells and plants with modified acetyl-coa formation | |
DE4439748A1 (en) | Method for changing the flowering behavior in plants | |
DE60216419T2 (en) | METHOD FOR PRODUCING PLANT SEAMS WITH CHANGED FIBER CONTENT AND CHANGED SEED BOWL | |
EP1156117A2 (en) | Methods for isolating modulators of carotenoid biosynthesis enzymes | |
DE10313795A1 (en) | Altered PPase expression in sugar beet | |
DE19600357C1 (en) | DNA sequence encoding a phosphoenolpyruvate phosphate translocator, plasmids, bacteria, yeasts and plants containing this transporter | |
WO1999011805A1 (en) | Recombinant dna molecules and method for increasing oil content in plants | |
DE10063879B4 (en) | Nucleic acids encoding vacuolar invertases, plant cells and plants containing them and their use | |
WO2000060101A1 (en) | Metabolic selection markers for plants | |
DE19632121C2 (en) | Transgenic plant cells and plants with altered acetyl-CoA formation | |
EP1198578A2 (en) | PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF | |
DE4438821A1 (en) | DNA encoding plant citrate synthase | |
DE4435366A1 (en) | DNA encoding plant citrate synthase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998954461 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2306205 Country of ref document: CA Ref country code: CA Ref document number: 2306205 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09564368 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11563/99 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1998954461 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998954461 Country of ref document: EP |